Durable Efficacy of Dolutegravir Plus Lamivudine in Antiretroviral Treatment-Naive Adults With HIV-1 Infection: 96-Week Results From the GEMINI-1 and GEMINI-2 Randomized Clinical Trials

Pedro Cahn, Juan Sierra Madero, José R Arribas, Andrea Antinori, Roberto Ortiz, Amanda E Clarke, Chien-Ching Hung, Jürgen K Rockstroh, Pierre-Marie Girard, Jörg Sievers, Choy Y Man, Rimgaile Urbaityte, Daisy J Brandon, Mark Underwood, Allan R Tenorio, Keith A Pappa, Brian Wynne, Martin Gartland, Michael Aboud, Jean van WykKimberly Y Smith

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Durable Efficacy of Dolutegravir Plus Lamivudine in Antiretroviral Treatment-Naive Adults With HIV-1 Infection: 96-Week Results From the GEMINI-1 and GEMINI-2 Randomized Clinical Trials'. Together they form a unique fingerprint.

Medicine & Life Sciences